Fifth salmeterol/fluticasone dry powder inhaler launched

Fixkoh Airmaster is the fifth salmeterol/fluticasone dry powder inhaler and the eleventh salmeterol/fluticasone inhaler to be listed in MIMS.

Fixkoh Airmaster (salmeterol/fluticasone) is indicated for use in asthma and COPD. | THORNTON & ROSS
Fixkoh Airmaster (salmeterol/fluticasone) is indicated for use in asthma and COPD. | THORNTON & ROSS

Fixkoh Airmaster is available in three strengths, providing pre-metered salmeterol/fluticasone doses of 50/100 microgram, 50/250 microgram and 50/500 microgram.

Like Seretide Accuhaler, Fixkoh Airmaster is licensed for the regular treatment of asthma where a long-acting β2-agonist (LABA) and inhaled corticosteroid (ICS) is appropriate; and for the symptomatic treatment of COPD in patients with a pre-bronchodilator FEV1 <60% predicted and a history of exacerbations who have significant symptoms despite regular bronchodilator therapy. It is suitable for patients from the age of 12 years.

The breath-actuated Airmaster device is primed by pressing the red button to slide open the mouthpiece cover until it clicks.

To compare Fixkoh Airmaster with existing LABA/ICS inhalers, prescribers can consult the MIMS comparison tables for asthma and COPD preparations, asthma combination inhalers, COPD combination inhalers, and breath-actuated inhalers. Images of the three strengths can be found in the MIMS visual guide to respiratory devices.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

NICE recommends SGLT2 inhibitors for chronic kidney disease

NICE recommends SGLT2 inhibitors for chronic kidney disease

Updated NICE guidance on type II diabetes recommends...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Avoid routinely offering antidepressants for 'less severe' depression, says NICE in draft guidance
Products coming soon - live tracker

Products coming soon - live tracker

EXCLUSIVE TO SUBSCRIBERS Monitor forthcoming UK drug...